ALK and leukemia: In a pediatric phase I trial, seven out of eight patients with ALK-positive anaplastic large cell lymphoma achieved a CR after treatment with crizotinib.4 Maesako et al.5 reported the efficacy of crizotinib in reducing leukemia cells in AML with ALK rearrangement.